Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
STRO
STRO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
STRO News
SUTRO BIOPHARMA INC.: WELLS FARGO INCREASES TARGET PRICE FROM $8 TO $27
Mar 24 2026
moomoo
Sutro Biopharma Reports 2025 Financial Results and Pipeline Updates
Mar 24 2026
NASDAQ.COM
Sutro Biopharma Receives Upgraded Rating
Mar 24 2026
Yahoo Finance
Sutro Biopharma Reports Disappointing Earnings Despite Revenue Growth
Mar 23 2026
seekingalpha
Sutro Biopharma Participates in World ADC Summit
Feb 23 2026
Newsfilter
Sutro Biopharma Prices 7.87M Share Offering at $13.98 Each
Feb 10 2026
seekingalpha
Sutro Biopharma CEO to Present at 44th J.P. Morgan Healthcare Conference
Jan 07 2026
Globenewswire
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg/day Dosing
Dec 19 2025
PRnewswire
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg/day Dosing
Dec 19 2025
Newsfilter
Sutro Biopharma Regains Nasdaq Compliance with $1 Share Price Post Reverse Split
Dec 17 2025
Globenewswire
Sutro Biopharma Regains Nasdaq Compliance with $1 Share Price Post Reverse Split
Dec 17 2025
Newsfilter
Sutro Biopharma Grants 24,500 Stock Options to Attract New Employees
Dec 16 2025
Globenewswire
Sutro Biopharma Grants 24,500 Stock Options to Attract New Employees
Dec 16 2025
Newsfilter
Sutro Biopharma Initiates Phase 1 Trial of STRO-004, Initial Data Expected Mid-2026
Dec 03 2025
Globenewswire
Sutro Biopharma Approves 1-for-10 Reverse Stock Split to Meet Nasdaq Compliance
Dec 01 2025
Globenewswire
Sutro Biopharma Implements 1-for-10 Reverse Stock Split
Dec 01 2025
NASDAQ.COM
Show More News
